Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2017

Jul 28, 2017

34519_dirs_2017-07-28_4905c795-6aa6-46c1-9943-da0b36777072.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2017-07-27

Reporting Person: Pessin Brian L. (See Explanation of Responses)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-07-27 Common Stock P 30000 $5.25 Acquired 70000 Direct

Footnotes

F1: The Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock.